Hypotensive transfusion reactions can occur with blood products that are leukoreduced before storage

Transfusion

Volumn 44, Issue 9, 2004, Pages 1361-1366

  Arnold, Donald M ^a   Molinaro, Giuseppe ^a   Warkentin, Theodore E ^a   DiTomasso, Julie ^a   Webert, Kathryn E ^a   Davis, Ian ^a   Lesiuk, Lawrence ^a   Dunn, Geoffrey ^a   Heddle, Nancy M ^a   Adam, Albert ^a   Blajchman, Morris A ^a  

^a HSC 2 N34 ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE P; BRADYKININ[1-8]; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HETASTARCH; KININ; METALLOPROTEINASE;

ADULT; ARTICLE; BEDSIDE WHITE CELL FILTRATION; BLOOD; BLOOD AUTOTRANSFUSION; BLOOD PRESSURE; BLOOD STORAGE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CASE REPORT; CELL SEPARATION; CRYSTALLOID; DEGRADATION; HEMODILUTION; HUMAN; HYPOTENSION; LEUKOREDUCTION; MALE; PROSTATECTOMY; RISK FACTOR;

ADENOCARCINOMA; AMINOPEPTIDASES; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD COMPONENT TRANSFUSION; BLOOD PRESERVATION; BLOOD TRANSFUSION, AUTOLOGOUS; BRADYKININ; FILTRATION; HEMODILUTION; HUMANS; HYPOTENSION; KININS; LEUKOCYTES; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 4344672726     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0041-1132.2004.04057.x     Document Type: Article

References (24)

1. Webert KE, Blajchman MA. Transfusion-related acute lung injury. Transfus Med Rev 2003;17:252-62.
2. Morduchowicz G, Pitlik SD, Huminer D, et al. Transfusion reactions due to bacterial contamination of blood and blood products. Rev Infect Dis 1991;13:307-14.
3. Domen RE, Hoeltge GA. Allergic transfusion reactions: an evaluation of 273 consecutive reactions. Arch Pathol Lab Med 2003;127:316-20.
4. Blais C Jr, Rouleau JL, Brown NJ, et al. Serum metabolism of bradykinin and Des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema. Immunopharmacology 1999;43:293-302.
5. Cyr M, Eastlund T, Blais C Jr, Rouleau JL, Adam A. Bradykinin metabolism and hypotensive transfusion reactions. Transfusion 2001;41:136-50.
6. Molinaro G, Cugno M, Perez M, et al. Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of Des-arginine (9)-bradykinin. J Pharmacol Exp Ther 2002;303:232-7.
7. Hild M, Soderstrom T, Egberg N, Lundahl J. Kinetics of bradykinin levels during and after leucocyte filtration of platelet concentrates. Vox Sang 1998;75:18-25.
8. Takahashi TA, Abe H, Hosoda M, Nakai K, Sekiguchi S. Bradykinin generation during filtration of platelet concentrates with a white cell-reduction filter. Transfusion 1995;35:967.
9. Quillen K. Hypotensive transfusion reactions in patients taking angiotensin-converting-enzyme inhibitors. N Engl J Med 2000;343:1422-3.
10. Zoon K, Jacobson ED, Woodcock J. Hypotension and bedside leukoreduction filters. CDRH Safety Alert. Rockville (MD): CBER Office of Communication, Training, and Manufacturers Assistance; 1999 May 4.
11. Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974;111:58-64.
12. Cyr M, Lepage Y, Blais C Jr, Gervais N, Cugno M, Rouleau JL, Adam A. Bradykinin and Des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma. Am J Physiol Heart Circ Physiol 2001;281:H275-83.
13. Hume HA, Adam A. Hypotensive transfusion reactions. In: Popovsky M, ed. Transfusion reactions. 2nd ed. Bethesda: American Association of Blood Banks; 2001:213-33.
14. Cyr M, Hume HA, Champagne M, et al. Anomaly of the Des-Arg9-bradykinin metabolism associated with severe hypotensive reactions during blood transfusions: a preliminary study. Transfusion 1999;39:1084-8.
15. Sweeney JD, Dupuis M, Mega AP. Hypotensive reactions to red cells filtered at the bedside, but not to those filtered before storage, in patients taking ACE inhibitors. Transfusion 1998;38:410-1.
16. Abe H, Ikebuchi K, Shimbo M, Sekiguchi S. Hypotensive reactions with a white cell-reduction filter: activation of a Kallikrein-Kinin cascade in a patient. Transfusion 1998;38:411-2.
17. Perseghin P, Capra M, Baldini V, Sciorelli G. Bradykinin production during donor plasmapheresis procedures. Vox Sang 2001;81:24-8.
18. Blais C Jr, Marc-Aurele J, Simmons WH, et al. Des-Arg9-bradykinin metabolism in patients who presented hypersensitivity reactions during hemodialysis: role of serum ACE and aminopeptidase P. Peptides 1999;20:421-30.
19. Molinaro G, Adam A, Lepage Y, et al. Hypotensive reaction during staphylococcal protein A column therapyin a patient with anomalous degradation of bradykinin and Des-Arg9-bradykinin after contact activation. Transfusion 2002;42:1458-65.
20. Maggiore Q. Isothermic dialysis for hypotension-prone patients. Semin Dial 2002;15:187-90.
21. Iwama H. Bradykinin-associated reactions in white cell-reduction filter. J Crit Care 2001;16:74-81.
22. Charlesworth MC, Young CY, Miller VM, Tindall DJ. Kininogenase activity of prostate-derived human glandular kallikrein (HK2) purified from seminal fluid. J Androl 1999;20:220-9.
23. Tu K, Mamdani MM, Jacka RM, et al. The striking effect of the heart outcomes prevention evaluation (HOPE) on ramipril prescribing in Ontario. CMAJ 2003;168:553-7.
24. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-53.